Naloxone for Opioid Toxicity and Overdose in the Community
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Coffin P, Behar E, Rowe C, Santos G, Coffa D, Bald M
. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016; 165(4):245-52.
PMC: 5783639.
DOI: 10.7326/M15-2771.
View
2.
Nielsen S, Peacock A, Lintzeris N, Bruno R, Larance B, Degenhardt L
. Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids. Pain Med. 2017; 19(3):533-540.
DOI: 10.1093/pm/pnx021.
View
3.
Dietze P, Stare M, Cogger S, Nambiar D, Olsen A, Burns L
. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities. Drug Alcohol Rev. 2018; 37(4):457-463.
DOI: 10.1111/dar.12644.
View
4.
Tse W, Sanfilippo P, Lam T, Dietze P, Nielsen S
. Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018. Med J Aust. 2020; 212(7):314-320.
DOI: 10.5694/mja2.50524.
View